Cell signalling of glucagon-like peptide-1 action in rat skeletal muscle
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Glucagon-like peptide-1 (GLP-1), an incretin with glucose-dependent insulinotropic and insulin-independent antidiabetic properties, has insulin-like effects on glucose metabolism in extrapancreatic tissues participating in overall glucose homeostasis. These effects are exerted through specific receptors not associated with cAMP, an inositol phosphoglycan being a possible second messenger. In rat hepatocytes, activation of phosphatidylinositol 3-kinase (PI3K)/protein kinase B (PKB), protein kinase C (PKC) and protein phosphatase 1 (PP-1) has been shown to be involved in the GLP-1-induced stimulation of glycogen synthase. We have investigated the role of enzymes known or suggested to mediate the actions of insulin in the GLP-1-induced increase in glycogen synthase a activity in rat skeletal muscle strips. We first explored the effect of GLP-1, compared with that of insulin, on the activation of PI3K, PKB, p70s6 kinase (p70s6k) and p44/42 mitogen-activated protein kinases (MAPKs) and the action of specific inhibitors of these kinases on the insulin- and GLP-1-induced increment in glycogen synthase a activity. The study showed that GLP-1, like insulin, activated PI3K/PKB, p70s6k and p44/42. Wortmannin (a PI3K inhibitor) reduced the stimulatory action of insulin on glycogen synthase a activity and blocked that of GLP-1, rapamycin (a 70s6k inhibitor) did not affect the action of GLP-1 but abolished that of insulin, PD98059 (MAPK inhibitor) was ineffective on insulin but blocked the action of GLP-1, okadaic acid (a PP-2A inhibitor) and tumour necrosis factor-alpha (a PP-1 inhibitor) were both ineffective on GLP-1 but abolished the action of insulin, and Ro 31-8220 (an inhibitor of some PKC isoforms) reduced the effect of GLP-1 while completely preventing that of insulin. It was concluded that activation of PI3K/PKB and MAPKs is required for the GLP-1-induced increment in glycogen synthase a activity, while PKC, although apparently participating, does not seem to play an essential role; unlike in insulin signaling, p70s6k, PP-1 and PP-2A do not seem to be needed in the action of GLP-1 upon glycogen synthase a activity in rat muscle.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Signaling pathways in insulin action: molecular targets of insulin resistance
Pessin, J. E., & Saltiel, A. R. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10582 · Cited by 939
Thorens, B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.18.8641 · Cited by 906
Gutniak, M., Ørkov, C., Holst, J. J., Ahrén, B., & Efendić, S. (1992) · New England Journal of Medicine · doi:10.1056/nejm199205143262003 · Cited by 868 · cited 2×
“…a possible tool for the therapy of type 2 diabetes (Gutniak et al. 1992); it has incretin character and insulin-independent antidiabetic properties (Gutniak et al. 1992, D’Alessio et al. 1995), and mimics the effects of insulin on glucose metabolism in the skeletal muscle and liver from normal…”
BackgroundMethodThe molecular mechanism by which insulin stimulates glycogen synthesis in mammalian skeletal muscle
Dent, P., Lavoinne, A., Nakielny, S., Caudwell, F. B., Watt, P., & Cohen, P. (1990) · Nature · doi:10.1038/348302a0 · Cited by 519
Buteau, J., Roduit, R., Susini, S., & Prentki, M. (1999) · Diabetologia · doi:10.1007/s001250051238 · Cited by 413 · cited 2×
“synthase activation by insulin in 3T3-L1 adipocytes ( Brady et al. 1997 ).”
BackgroundLazar, D. F., Wiese, R. J., Brady, M. J., Mastick, C. C., Waters, S. B., Yamauchi, K., Pessin, J. E., Cuatrecasas, P., & Saltiel, A. R. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.35.20801 · Cited by 396
Shepherd, P. R., Navé, B. T., & Siddle, K. (1995) · Biochemical Journal · doi:10.1042/bj3050025 · Cited by 277 · cited 3×
“1996) and also in 3T3-L1 adipocytes (Shepherd et al. 1995) but not in rat adipocytes (Moule et al.”
BackgroundConsidine, R. V., Nyce, M. R., Allen, L. E., Morales, L. M., Triester, S., Serrano, J., Colberg, J., Lanza-Jacoby, S., & Caro, J. F. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118001 · Cited by 141 · cited 1×
“Also, it has been reported that activation of PKC or PKC induces Glut-4 translocation (Pessin & Saltiel 2000), and that several PKC isoforms are chronically activated in human and animal models of insulin resistance (Considine et al. 1995, Avignon et al. 1996, Ishizuka et al. 1998).”
BackgroundEffect of GLP-1 on lipid metabolism in human adipocytes
Villanueva-Peñacarrillo, M. L., Márquez, L., González, N., Díaz-Miguel*, M., & Valverde, I. (2001) · Hormone and Metabolic Research · doi:10.1055/s-2001-12428 · Cited by 113
Self-citationGLP-1 (7-36) amide: Effects on glucose transport and metabolism in rat adipose tissue
Perea, A., Viñambres, C., Clemente, F., Villanueva-Peñacarrillo, M., & Valverde, I. (1997) · Hormone and Metabolic Research · doi:10.1055/s-2007-979068 · Cited by 53
Self-citation
Cited by
The role of incretins in glucose homeostasis and diabetes treatment
Kim, W., & Egan, J. M. (2008) · Pharmacological Reviews · doi:10.1124/pr.108.000604 · Cited by 824
“…not Ex-9-39, stimulated glycogen synthase a activity and glycogen synthesis in association with activation of PI-3K/PKB and p42/44 MAPK pathways (Acitores et al., 2004; González et al., 2005), and they also stimulated glucose oxidation and utilization, as did insulin (Alcántara et al., 1997;…”
Gupta, N. A., Mells, J., Dunham, R. M., Grakoui, A., Handy, J., Saxena, N. K., & Anania, F. A. (2010) · Hepatology · doi:10.1002/hep.23569 · Cited by 532
“The principle pleotropic effects of GLP-1 include enhanced satiety, delayed gastric emptying,(4,5) and increased lower gastrointestinal motility.(1,6) GLP-1 binds to its cognate receptor, glucagonlike peptide 1 receptor (GLP-1R), a G protein– coupled receptor (GPCR) that has been found in many tissues, including the b…”
BackgroundPleiotropic Effects of GLP-1 and Analogs on Cell Signaling, Metabolism, and Function
Rowlands, J., Heng, J., Newsholme, P., & Carlessi, R. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00672 · Cited by 302
Pipatpiboon, N., Pintana, H., Pratchayasakul, W., Chattipakorn, N., & Chattipakorn, S. C. (2013) · European Journal of Neuroscience · doi:10.1111/ejn.12088 · Cited by 183
“…effect, as demonstrated previously that it could activate the PI3K/PKB pathway in skeleton muscle, liver and myocytes (Redondo et al., 2003; Acitores et al., 2004; Gonzalez et al., 2005), an increment of the brain GLP-1 level could directly improve neuronal IR function via this mechanism.”
BackgroundPerna, S., Guido, D., Bologna, C., Solerte, S. B., Guerriero, F., Isu, A., & Rondanelli, M. (2016) · Aging Clinical and Experimental Research · doi:10.1007/s40520-015-0525-y · Cited by 125
Metadata
- Authors
- Acitores, A., Gonzalez, N., Sancho, V, Valverde, I., & Villanueva-Penacarrillo, M.
- Venue
- Journal of Endocrinology
- Publisher
- Bioscientifica
- Published
- 2004-03-01
- Volume
- 180
- Issue
- 3
- Pages
- 389-398
- ISSN
- 0022-0795 (ISSN-L)
- 1479-6805
- OpenAlex
- W2141329457
- Cited by
- 55
- References
- 10
- FWCI
- 1.53
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cell signalling of glucagon-like peptide-1 action in rat skeletal muscle. https://app.cochat.ai/papers/10.1677/joe.0.1800389
- The paper
- Acitores, A., Gonzalez, N., Sancho, V, Valverde, I., & Villanueva-Penacarrillo, M. (2004). Cell signalling of glucagon-like peptide-1 action in rat skeletal muscle. Journal of Endocrinology. https://doi.org/10.1677/joe.0.1800389
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.